# NRG Energy, Inc.: financial statements, quarterly

NRG · NYSE · CIK 1013871 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nrg.md) · [Financials](/companies/nrg/financials.md) · [Filings](/companies/nrg/filings.md) · [Insiders](/companies/nrg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nrg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [7.9](/filings/0001013871-24-000020.md) | [6.7 d](/filings/0001013871-26-000004.md) | [7.4](/filings/0001013871-25-000013.md) | [6.5](/filings/0001013871-25-000020.md) | [7.1](/filings/0001013871-25-000025.md) | [6.8 d](/filings/0001013871-26-000004.md) | [8.5](/filings/0001013871-26-000012.md) | [6.7](/filings/0001013871-26-000020.md) | [7.5](/filings/0001013871-25-000025.md) | [7.7 d](/filings/0001013871-26-000004.md) | [10.1](/filings/0001013871-26-000012.md) | [7.3](/filings/0001013871-26-000020.md) |
| Cost of revenue | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $bn | [0.6](/filings/0001013871-24-000020.md) | [0.6 d](/filings/0001013871-26-000004.md) | [0.5](/filings/0001013871-25-000013.md) | [0.5](/filings/0001013871-25-000020.md) | [0.6](/filings/0001013871-25-000025.md) | [0.6 d](/filings/0001013871-26-000004.md) | [0.5](/filings/0001013871-26-000012.md) | [0.7](/filings/0001013871-26-000020.md) | [0.6](/filings/0001013871-25-000025.md) | [0.7 d](/filings/0001013871-26-000004.md) | [0.6](/filings/0001013871-26-000012.md) | [0.6](/filings/0001013871-26-000020.md) |
| Operating income | $bn | [0.6](/filings/0001013871-24-000020.md) | [0.8 d](/filings/0001013871-26-000004.md) | [0.9](/filings/0001013871-25-000013.md) | [1.4](/filings/0001013871-25-000020.md) | [(0.8)](/filings/0001013871-25-000025.md) | [1.0 d](/filings/0001013871-26-000004.md) | [1.1](/filings/0001013871-26-000012.md) | [0.0](/filings/0001013871-26-000020.md) | [0.4](/filings/0001013871-25-000025.md) | [0.3 d](/filings/0001013871-26-000004.md) | [0.3](/filings/0001013871-26-000012.md) | [1.0](/filings/0001013871-26-000020.md) |
| Interest expense | $bn | [0.2](/filings/0001013871-23-000022.md) | [0.2 d](/filings/0001013871-24-000005.md) | [0.2](/filings/0001013871-24-000010.md) | [0.2](/filings/0001013871-25-000020.md) | [0.2](/filings/0001013871-25-000025.md) | [0.1 d](/filings/0001013871-26-000004.md) | [0.2](/filings/0001013871-26-000012.md) | [0.1](/filings/0001013871-26-000020.md) | [0.2](/filings/0001013871-25-000025.md) | [0.2 d](/filings/0001013871-26-000004.md) | [0.3](/filings/0001013871-26-000012.md) | [0.3](/filings/0001013871-26-000020.md) |
| Income tax | $bn | [0.1](/filings/0001013871-24-000020.md) | [0.2 d](/filings/0001013871-26-000004.md) | [0.2](/filings/0001013871-25-000013.md) | [0.3](/filings/0001013871-25-000020.md) | [(0.2)](/filings/0001013871-25-000025.md) | [0.1 d](/filings/0001013871-26-000004.md) | [0.2](/filings/0001013871-26-000012.md) | [(0.0)](/filings/0001013871-26-000020.md) | [0.1](/filings/0001013871-25-000025.md) | [(0.0) d](/filings/0001013871-26-000004.md) | [(0.0)](/filings/0001013871-26-000012.md) | [0.2](/filings/0001013871-26-000020.md) |
| Net income | $bn | [0.3](/filings/0001013871-24-000020.md) | [0.5 d](/filings/0001013871-26-000004.md) | [0.5](/filings/0001013871-25-000013.md) | [0.7](/filings/0001013871-25-000020.md) | [(0.8)](/filings/0001013871-25-000025.md) | [0.6 d](/filings/0001013871-26-000004.md) | [0.8](/filings/0001013871-26-000012.md) | [(0.1)](/filings/0001013871-26-000020.md) | [0.2](/filings/0001013871-25-000025.md) | [0.1 d](/filings/0001013871-26-000004.md) | [0.1](/filings/0001013871-26-000012.md) | [0.5](/filings/0001013871-26-000020.md) |
| Diluted EPS | $ per share | [1.41](/filings/0001013871-24-000020.md) | not reported | [2.31](/filings/0001013871-25-000013.md) | [3.37](/filings/0001013871-25-000020.md) | [(3.79)](/filings/0001013871-25-000025.md) | not reported | [3.61](/filings/0001013871-26-000012.md) | [(0.62)](/filings/0001013871-26-000020.md) | [0.69](/filings/0001013871-25-000025.md) | not reported | [0.52](/filings/0001013871-26-000012.md) | [2.31](/filings/0001013871-26-000020.md) |
| Basic EPS | $ per share | [1.42](/filings/0001013871-24-000020.md) | not reported | [2.36](/filings/0001013871-25-000013.md) | [3.47](/filings/0001013871-25-000020.md) | [(3.79)](/filings/0001013871-25-000025.md) | not reported | [3.70](/filings/0001013871-26-000012.md) | [(0.62)](/filings/0001013871-26-000020.md) | [0.70](/filings/0001013871-25-000025.md) | not reported | [0.52](/filings/0001013871-26-000012.md) | [2.32](/filings/0001013871-26-000020.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.4](/filings/0001013871-23-000022.md) | [0.5](/filings/0001013871-26-000004.md) | [0.3](/filings/0001013871-24-000010.md) | [0.4](/filings/0001013871-24-000015.md) | [1.1](/filings/0001013871-24-000020.md) | [1.0](/filings/0001013871-26-000004.md) | [0.7](/filings/0001013871-25-000013.md) | [0.2](/filings/0001013871-25-000020.md) | [0.7](/filings/0001013871-25-000025.md) | [4.7](/filings/0001013871-26-000020.md) | [0.2](/filings/0001013871-26-000012.md) | [0.2](/filings/0001013871-26-000020.md) |
| Current assets | $bn | [9.5](/filings/0001013871-23-000022.md) | [9.7](/filings/0001013871-25-000006.md) | [9.3](/filings/0001013871-24-000010.md) | [9.8](/filings/0001013871-24-000015.md) | [8.6](/filings/0001013871-24-000020.md) | [9.0](/filings/0001013871-26-000004.md) | [9.9](/filings/0001013871-25-000013.md) | [8.2](/filings/0001013871-25-000020.md) | [8.1](/filings/0001013871-25-000025.md) | [13.1](/filings/0001013871-26-000020.md) | [9.9](/filings/0001013871-26-000012.md) | [9.7](/filings/0001013871-26-000020.md) |
| Total assets | $bn | [27.9](/filings/0001013871-23-000022.md) | [26.0](/filings/0001013871-25-000006.md) | [25.4](/filings/0001013871-24-000010.md) | [25.8](/filings/0001013871-24-000015.md) | [23.7](/filings/0001013871-24-000020.md) | [24.0](/filings/0001013871-26-000004.md) | [25.0](/filings/0001013871-25-000013.md) | [24.1](/filings/0001013871-25-000020.md) | [24.0](/filings/0001013871-25-000025.md) | [29.1](/filings/0001013871-26-000020.md) | [40.1](/filings/0001013871-26-000012.md) | [39.9](/filings/0001013871-26-000020.md) |
| Current liabilities | $bn | [8.9](/filings/0001013871-23-000022.md) | [9.5](/filings/0001013871-25-000006.md) | [9.2](/filings/0001013871-24-000010.md) | [8.3](/filings/0001013871-24-000015.md) | [7.3](/filings/0001013871-24-000020.md) | [8.8](/filings/0001013871-26-000004.md) | [9.3](/filings/0001013871-25-000013.md) | [8.8](/filings/0001013871-25-000020.md) | [7.7](/filings/0001013871-25-000025.md) | [8.0](/filings/0001013871-26-000020.md) | [11.8](/filings/0001013871-26-000012.md) | [10.0](/filings/0001013871-26-000020.md) |
| Total liabilities | $bn | [24.4](/filings/0001013871-23-000022.md) | [23.1](/filings/0001013871-25-000006.md) | [22.1](/filings/0001013871-24-000010.md) | [22.1](/filings/0001013871-24-000015.md) | [21.2](/filings/0001013871-24-000020.md) | [21.5](/filings/0001013871-26-000004.md) | [22.2](/filings/0001013871-25-000013.md) | [21.8](/filings/0001013871-25-000020.md) | [22.0](/filings/0001013871-25-000025.md) | [27.5](/filings/0001013871-26-000020.md) | [35.2](/filings/0001013871-26-000012.md) | [35.1](/filings/0001013871-26-000020.md) |
| Long-term debt | $bn | [10.7](/filings/0001013871-23-000022.md) | [10.1](/filings/0001013871-24-000020.md) | [9.6](/filings/0001013871-24-000010.md) | [10.4](/filings/0001013871-24-000015.md) | [10.4](/filings/0001013871-24-000020.md) | [9.8](/filings/0001013871-25-000025.md) | [9.8](/filings/0001013871-25-000013.md) | [9.8](/filings/0001013871-25-000020.md) | [11.2](/filings/0001013871-25-000025.md) | [16.4](/filings/0001013871-26-000012.md) | [19.8](/filings/0001013871-26-000012.md) | [23.4](/filings/0001013871-26-000020.md) |
| Current portion of debt | $bn | [0.9](/filings/0001013871-23-000022.md) | [0.6](/filings/0001013871-24-000020.md) | [1.1](/filings/0001013871-24-000010.md) | [0.3](/filings/0001013871-24-000015.md) | [0.3](/filings/0001013871-24-000020.md) | [1.0](/filings/0001013871-25-000025.md) | [1.0](/filings/0001013871-25-000013.md) | [1.1](/filings/0001013871-25-000020.md) | [0.8](/filings/0001013871-25-000025.md) | [0.0](/filings/0001013871-26-000020.md) | [3.4](/filings/0001013871-26-000012.md) | [1.5](/filings/0001013871-26-000020.md) |
| Shareholders' equity | $bn | [3.5](/filings/0001013871-24-000020.md) | [2.9](/filings/0001013871-26-000004.md) | [3.3](/filings/0001013871-25-000025.md) | [3.6](/filings/0001013871-25-000025.md) | [2.5](/filings/0001013871-25-000025.md) | [2.5](/filings/0001013871-26-000020.md) | [2.8](/filings/0001013871-26-000020.md) | [2.3](/filings/0001013871-26-000020.md) | [2.0](/filings/0001013871-25-000025.md) | [1.7](/filings/0001013871-26-000020.md) | [4.9](/filings/0001013871-26-000020.md) | [4.9](/filings/0001013871-26-000020.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [566 d](/filings/0001013871-24-000020.md) | [241 d](/filings/0001013871-26-000004.md) | [267](/filings/0001013871-25-000013.md) | [1,056 d](/filings/0001013871-25-000020.md) | [31.0 d](/filings/0001013871-25-000025.md) | [952 d](/filings/0001013871-26-000004.md) | [855](/filings/0001013871-26-000012.md) | [451 d](/filings/0001013871-26-000020.md) | [484 d](/filings/0001013871-25-000025.md) | [123 d](/filings/0001013871-26-000004.md) | [(169)](/filings/0001013871-26-000012.md) | [1,117 d](/filings/0001013871-26-000020.md) |
| Capital expenditure | $m | [169 d](/filings/0001013871-24-000020.md) | [105 d](/filings/0001013871-26-000004.md) | [69.0](/filings/0001013871-25-000013.md) | [103 d](/filings/0001013871-25-000020.md) | [114 d](/filings/0001013871-25-000025.md) | [186 d](/filings/0001013871-26-000004.md) | [217](/filings/0001013871-26-000012.md) | [378 d](/filings/0001013871-26-000020.md) | [254 d](/filings/0001013871-25-000025.md) | [298 d](/filings/0001013871-26-000004.md) | [317](/filings/0001013871-26-000012.md) | [338 d](/filings/0001013871-26-000020.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [50.0 d](/filings/0001013871-24-000020.md) | [1,100 d](/filings/0001013871-26-000004.md) | [0.0](/filings/0001013871-25-000013.md) | [90.0 d](/filings/0001013871-25-000020.md) | [226 d](/filings/0001013871-25-000025.md) | [619 d](/filings/0001013871-26-000004.md) | [314](/filings/0001013871-26-000012.md) | [289 d](/filings/0001013871-26-000020.md) | [355 d](/filings/0001013871-25-000025.md) | [353 d](/filings/0001013871-26-000004.md) | [481](/filings/0001013871-26-000012.md) | [450 d](/filings/0001013871-26-000020.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [235](/filings/0001013871-23-000022.md) | [230](/filings/0001013871-24-000010.md) | [232](/filings/0001013871-24-000015.md) | [232](/filings/0001013871-24-000020.md) | [214](/filings/0001013871-25-000013.md) | [214](/filings/0001013871-25-000020.md) | [207](/filings/0001013871-25-000025.md) | [203](/filings/0001013871-26-000012.md) | [196](/filings/0001013871-26-000020.md) | [195](/filings/0001013871-25-000025.md) | [208](/filings/0001013871-26-000012.md) | [212](/filings/0001013871-26-000020.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 210,210,483 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001013871-26-000020.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.